A growing shortage of common cancer treatments is forcing doctors to switch medications and delay some treatments, leading US cancer centers say. The National Comprehensive Cancer Network said Wednesday that nearly every center it surveyed late last month was dealing with deficiencies in carboplatin and cisplatin, a pair of drugs used to treat a range of cancers. Some are no longer able to treat patients receiving carboplatin at the intended dose or schedule. Kari Wisinski has had to turn to other treatments for some patients or change the order in…
Read More